crp
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | |||
| crp [2026/10/14 14:16] – [Causes of minimal elevations of CRP] gary1 | crp [2026/10/14 14:18] (current) – [Introduction] gary1 | ||
|---|---|---|---|
| Line 33: | Line 33: | ||
| * "among individuals with known cardiovascular disease both treated and not treated with statins, hsCRP is at least as powerful a predictor of recurrent vascular events as that of LDL cholesterol, | * "among individuals with known cardiovascular disease both treated and not treated with statins, hsCRP is at least as powerful a predictor of recurrent vascular events as that of LDL cholesterol, | ||
| * "among individuals taking statin therapy, consideration should be given to increase dosage into the higher intensity range if hsCRP levels remain >2 mg/L, irrespective of LDL cholesterol." | * "among individuals taking statin therapy, consideration should be given to increase dosage into the higher intensity range if hsCRP levels remain >2 mg/L, irrespective of LDL cholesterol." | ||
| + | * >2 mg/L may signal early disease: average hs-CRP nearly doubled between stage 0 and stage 1 cardiovascular–kidney–metabolic syndrome, the largest change seen across all stages, and crossed 2 mg/L, the level commonly used to signal increased cardiovascular risk(([[https:// | ||
| * elevated soluble uPAR (suPAR) levels may be an even better marker of atherosclerotic cardiovascular disease (CVD) phenotypes | * elevated soluble uPAR (suPAR) levels may be an even better marker of atherosclerotic cardiovascular disease (CVD) phenotypes | ||
| </ | </ | ||
crp.txt · Last modified: 2026/10/14 14:18 by gary1